This grant is for the purpose of establishing an epidemiologic cohort study focusing on Interstitial Cystitis (IC). The primary goal is to follow a well-defined cohort of IC participants to estimate incidence, characterize demographic and clinical patterns, and document the long-term health impact of the condition. Furthermore, this funding opportunity aims to translate scientific knowledge gained from this and previous studies into actionable public health practices. This includes developing patient strategies for improving quality of life, enhancing provider and patient awareness and education about IC, and advancing medical and self-management approaches. The initiative seeks to strengthen clinical, community, and public health linkages, specifically targeting groups disproportionately affected by IC to improve outcomes.
Opportunity ID: 327721
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 9 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Jan 07, 2021 |
| Original Closing Date for Applications: | Jan 14, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Jan 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 18, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” County governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities State governments City or township governments Private institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Small businesses Special district governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The Q&A’s for RFA-DP-21-002 Epidemiologic Cohort Study of Interstitial Cystitis has been added under the RELATED DOCUMENTS tab. Please view these questions and responses to assist in completing your application. | Jan 07, 2021 | |
| The Q&A’s for RFA-DP-21-002 Epidemiologic Cohort Study of Interstitial Cystitis has been added under the RELATED DOCUMENTS tab. Please view these questions and responses to assist in completing your application. | Nov 10, 2020 | |
| The Q&A’s for RFA-DP-21-002 Epidemiologic Cohort Study of Interstitial Cystitis has been added under the RELATED DOCUMENTS tab. Please view these questions and responses to assist in completing your application. | Nov 10, 2020 | |
| Changed the NOFO due date from January 14, 2020 to January 19, 2020. | Nov 10, 2020 | |
| Changed the NOFO due date from January 14, 2020 to January 19, 2020. | Nov 10, 2020 | |
| Changed the application Due date from January 14, 2020 to January 19, 2020. | Nov 10, 2020 | |
| Updated Agency Contact | Nov 10, 2020 | |
| Completed Final NOFO upload | Nov 10, 2020 | |
| Nov 10, 2020 | ||
| Jun 16, 2020 |
DISPLAYING: Synopsis 9
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 9 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Jan 07, 2021 |
| Original Closing Date for Applications: | Jan 14, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Jan 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 18, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” County governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities State governments City or township governments Private institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Small businesses Special district governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Synopsis 8
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 8 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Jan 07, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 18, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Synopsis 7
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 7 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Jan 07, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 18, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Synopsis 6
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 6 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Nov 13, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 18, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Nov 13, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 18, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Nov 13, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 18, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Nov 13, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 14, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 13, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Nov 13, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 14, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 13, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 10, 2020 |
| Last Updated Date: | Nov 10, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 14, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 13, 2021 |
| Estimated Total Program Funding: | $2,490,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | This NOFO is open competition |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dionne Godette
qal6@cdc.gov Email:qal6@cdc.gov |
DISPLAYING: Forecast 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-21-002 |
| Funding Opportunity Title: | Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 1 |
| Posted Date: | Jun 16, 2020 |
| Last Updated Date: | Jun 16, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | – |
| Estimated Total Program Funding: | $2,500,000 |
| Award Ceiling: | $900,000 |
| Award Floor: | $830,000 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Small businesses Special district governments Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions For-Profit Organizations (Other than Small Businesses) Indian/Native American Tribal Governments (Other than Federally Recognized) Eligible Agencies of the Federal Government U.S. Territory or Possession Faith-based or Community-based Organizations Regional Organizations Bona Fide Agents Federally Funded Research and Development Centers (FFRDCs) |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this NOFO will include translating the scientific knowledge on IC extracted from this and prior studies, so it can be used to support public health action, including patient strategies for improving quality of life, provider and patient awareness and education, and medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:qal6@cdc.gov |
Related Documents
Folder 327721 Full Announcement-RFA-DP-21-002 -> DP21-002_Final NOFO_11 13 2020 pdf.pdf
Folder 327721 Full Announcement-RFA-DP-21-002 -> Q&A Potential Applicant Questions_1-7-2021.pdf
Packages
| Agency Contact Information: | Dionne Godette qal6@cdc.gov Email: qal6@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.283 | RFA-DP-21-002 | Epidemiologic Cohort Study of Interstitial Cystitis | PKG00264065 | Nov 10, 2020 | Jan 19, 2021 | View |
Package 1
Mandatory forms
327721 RR_SF424_2_0-2.0.pdf
327721 RR_Budget_1_4-1.4.pdf
327721 PHS398_ResearchPlan_4_0-4.0.pdf
327721 PHS398_CoverPageSupplement_5_0-5.0.pdf
327721 RR_OtherProjectInfo_1_4-1.4.pdf
327721 PerformanceSite_2_0-2.0.pdf
327721 RR_KeyPersonExpanded_2_0-2.0.pdf
327721 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
327721 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
